CD274 and Sepsis: It has also been demonstrated that utilization of either PD-1 or PD-L1 antibodies in blood donor restores neutrophil and monocyte function and reverses T-cell exhaustion supporting that immunoadjuvant therapies that are effective in cancer may be a potential target in patients with sepsis.